GSK’s Imigran Recovery Is First Triptan Approved For Nonprescription UK Sale
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline expects to make nonprescription Imigran Recovery (sumatriptan 50 mg) available in the UK in mid-June following approval for pharmacy sale by the Medicines & Healthcare products Regulatory Agency